Takeda announced a new multiyear restructuring program. This program will eliminate approximately 4,500 roles during the 2026 fiscal year. The company expects to incur $1.07 billion in restructuring costs. It projects over $1.26 billion in annualized savings by 2028. These changes aim to accelerate growth and support new product launches.
https://www.fiercepharma.com/pharma/takeda-slimming-down-new-era-plots-4500-layoffs-latest-restructuring-drive